Clinical Trial Update: Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative trastuzumab, pertuzumab, and letrozole in endocrine-sensitive HER2-positive, hormone receptor-positive breast cancer patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Endocrine Sensitive HER2+/HR+ Breast Cancer | Phase 2 | Status: COMPLETED